Skip to content

Newsroom

Future Fields Closes Oversubscribed $8M Series A to Turn Flies Into Bioreactors That Address Undruggable Diseases

Featured Story
Two professionals standing outside a modern building with greenery around.
View All Press Releases

As Seen In

Axios Exclusive: Future Fields raises $8M Series A round

07/17/2025

BDC, Amplify back insect protein biomanufacture in US$8M Series A

07/17/2025

AgFunder Future Fields raises $8m Series A to expand fruit fly biomanufacturing platform: ‘Clients come to us because they’ve struggled to make proteins in legacy platforms’

07/17/2025

FiercePharma Future Fields looks to solve industry’s biomanufacturing woes with fruit fly-based protein production

11/12/2024

Genetic Engineering & Biotechnology News Future Fields and Jenthera Use Fruit Flies for In Vivo CRISPR Therapy

06/14/2023

GlobalNews How an Edmonton biotech company is using fruit flies to potentially save lives

06/13/2023

Fast Company Why fruit flies could hold the secret to scaling up lab-grown meat and other bioproducts

02/27/2023

TechCrunch Future Fields is turning flies into bioreactors for recombinant protein production

02/22/2023

Forbes Thinking Outside The Tank: Why This Startup Thinks Fruit Flies Will Solve Synbio’s Scale-Up Problem

02/22/2023

Toyota Ventures Technology giant Toyota Ventures invests in Future Fields to scale their biomanufacturing capacity

02/22/2023

Amplify Capital Biotech means cleantech: Impact firm Amplify Capital invests in Future Fields

02/22/2023

Betakit Future Fields raises $15.1 million CAD to equip more industries with bioreactors by using fruit flies

02/22/2023

SDTC: Sustainable Development Technology Canada SDTC invests in made-in-Canada sustainable solutions like Future Fields

02/17/2023

Food Navigator USA Could fruit flies slash the cost of growth media for cell cultured meat? Future Fields says yes

02/14/2022

TechCrunch Future Fields is tackling cultured meat’s biggest problem

08/02/2020

Future Fields is a fly biotechnology company based in Edmonton, Canada.

Founded in 2018, Future Fields is on a mission to change how we do science for humanity and the planet.

Our biomanufacturing platform, the EntoEngine™, is the first synthetic biology system in the world to use fruit flies for recombinant protein production. Powered by people and fly by design, we’re equipping industries with the biomolecular tools they need to sustainably, ethically, and economically conduct great science.

As of 2023, our lab has been Green-certified by My Green Lab, and our FGF2 are the first growth factors in the world to receive the ACT Environmental Impact Factor Label. Future Fields is a proud business member of 1% for the Planet and the United Nations Global Compact initiative. Learn more about how we’re transforming science at futurefields.io.

Media Contact:

media@futurefields.io